250k more shares15 Dec 2017 09:33
250,000,000 Performance Shares will be converted into the same number of ordinary shares in Pharmanet upon the announcement of a JORC compliant Indicated or Measured Resource of at least 500,000oz of gold at the Klondyke Project within 18 months of Completion;
For Pharmanet now read Calidus.
This is the first milestone from RNS 28th April.
Further 275,000 shares trigger on commercially viable pre-feasibility study for the Klondyke